Reason for request
Inscription
Mise à disposition d'un médicament similaire à TRAVATAN 40 µg/ml, collyre en solution mais formulé sans conservateur.
Clinical Benefit
| Substantial |
Le service médical rendu par VIZITRAV 40 µg/ml, collyre en solution est important dans les indications de l’AMM. |
Clinical Added Value
| no clinical added value |
VIZITRAV 40 µg/ml, collyre en solution n’apporte pas d’amélioration du service médical rendu (ASMR V) par rapport à TRAVATAN 40 µg/ml, collyre en solution. |
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
tjEbWb1YC4VTCdM8
